USPTO Examiner ASHINE FIKIRTE T - Art Unit 3798

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
17105772ULTRASONIC DIAGNOSTIC APPARATUSNovember 2020August 2024Abandon4450YesNo
17062671ULTRASOUND SYSTEM AND METHOD FOR CONTROLLING ULTRASOUND SYSTEMOctober 2020March 2024Allow4140YesNo
17038455ULTRASONIC DIAGNOSTIC APPARATUS AND ULTRASONIC DIAGNOSTIC METHODSeptember 2020August 2024Abandon4740YesNo
17038810ACCELERATED ACQUISITION OF SCAN DATA BY MEANS OF MAGNETIC RESONANCESeptember 2020December 2023Allow3920YesNo
16968231System and Method for Detecting Small Blood-Tissue Barrier DisruptionAugust 2020November 2024Allow5250YesNo
16768290DEVICE AND METHOD FOR PROVIDING INFORMATION ABOUT A BIOPSY TAKING PROCESS AND BIOPSYMay 2020September 2024Allow5150NoYes
16880458APPARATUS AND METHOD FOR ESTIMATING BIO-INFORMATIONMay 2020December 2023Allow4330YesNo
16743418Tumor Tissue Characterization using Multi-Parametric Magnetic Resonance ImagingJanuary 2020January 2024Allow4841YesNo
16616571TRANSPERINEAL STEPPER INCLUDING A GEARLESS LINEAR MOVEMENTNovember 2019October 2023Allow4620NoNo
16576759METHOD OF GENERATING A MODEL FOR HEART RATE ESTIMATION FROM A PHOTOPLETHYSMOGRAPHY SIGNAL AND A METHOD AND A DEVICE FOR HEART RATE ESTIMATIONSeptember 2019February 2025Abandon6050YesNo
16512653DEEP LEARNING FOR PERFUSION IN MEDICAL IMAGINGJuly 2019May 2024Allow5840NoNo
16384795METHOD FOR JOINT ARTERIAL INPUT FUNCTION AND TRACER KINETIC PARAMETER ESTIMATION IN ACCELERATED DCE-MRI USING A MODEL CONSISTENCY CONSTRAINTApril 2019January 2024Allow5730YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner ASHINE, FIKIRTE T.

Strategic Value of Filing an Appeal

Total Appeal Filings
1
Allowed After Appeal Filing
1
(100.0%)
Not Allowed After Appeal Filing
0
(0.0%)
Filing Benefit Percentile
99.9%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 100.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner ASHINE, FIKIRTE T - Prosecution Strategy Guide

Executive Summary

Examiner ASHINE, FIKIRTE T works in Art Unit 3798 and has examined 12 patent applications in our dataset. With an allowance rate of 75.0%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 48 months.

Allowance Patterns

Examiner ASHINE, FIKIRTE T's allowance rate of 75.0% places them in the 42% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by ASHINE, FIKIRTE T receive 3.83 office actions before reaching final disposition. This places the examiner in the 95% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by ASHINE, FIKIRTE T is 48 months. This places the examiner in the 10% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a -33.3% benefit to allowance rate for applications examined by ASHINE, FIKIRTE T. This interview benefit is in the 1% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 25.0% of applications are subsequently allowed. This success rate is in the 42% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 25.0% of cases where such amendments are filed. This entry rate is in the 36% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 100% percentile among all examiners. Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 0.0% are granted (fully or in part). This grant rate is in the 7% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 48% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 54% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.